Home / Capabilities
Sector
Healthcare, Life Sciences and Pharmaceuticals
We act for hospitals, pharmaceutical and medical-device companies, health insurers, digital-health providers and investors across a health system in structural change.
Overview
Healthcare in East Africa is moving from a fragmented, largely out-of-pocket model towards an insured, institutional and increasingly digital system. Public-private partnerships in health are being structured at scale, pharmaceutical manufacturing is being onshored under the AfCFTA, medical-device regulation is being modernised and digital health is reaching every level of care. We advise providers, manufacturers, insurers and investors on licensing, transactions, data and the regulatory change that runs through all of it.
Related practices
The regulatory framework
The framework includes the Health Act 2017, the Pharmacy and Poisons Act, the Medical Practitioners and Dentists Act, the Public Health Act and the Health Records and Information Managers Act, together with the Social Health Insurance Act 2023, the Digital Health Act 2023 and the Primary Health Care Act 2023. Patient data is regulated with particular strictness under the Data Protection Act 2019. Oversight is shared by the Pharmacy and Poisons Board, the Kenya Medical Practitioners and Dentists Council, the Kenya Health Professions Oversight Authority and the Social Health Authority.
Speak to us
To discuss how we can help, email us at info@remingtonllp.com or visit our contacts page.
Our offering
We advise across care delivery, products and payment. Our team advises on:
▪ Hospitals and clinical operations: licensing, governance and clinical-risk management
▪ Pharmaceuticals: manufacturing, distribution, marketing authorisations and recalls
▪ Medical devices: market-entry approvals, import requirements and product liability
▪ Digital health: patient-data governance and cross-border telemedicine
▪ Health insurance: regulatory alignment, provider contracting and managed care
▪ Clinical research: ethics approvals, research agreements and intellectual property
Representative matters
▪ Acted for a regional hospital group on the structuring and financing of a tertiary-care facility under a public-private partnership with a county government.
▪ Advised a multinational pharmaceutical manufacturer on Pharmacy and Poisons Board registration, marketing-authorisation transfers and product-recall procedures.
▪ Advised a digital-health platform on its registration with the Office of the Data Protection Commissioner and its clinical-data sharing arrangements with a teaching hospital.
▪ Advised an international medical-device manufacturer on the regulatory pathway for introducing a diagnostic device to the East African market.
▪ Advised a regional health insurer on the structure and risk allocation of a value-based-care contract across its provider network.
.png)